Homeopathic Oral Spray Temper Tamer Recalled for CGMP Deviations
Siddha Flower Essences is voluntarily recalling Temper Tamer homeopathic oral spray due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall, and the source text does not report any illnesses, injuries, or deaths. CGMP deviations represent potential manufacturing control issues rather than a confirmed hazard to consumers. Per the rubric, FDA Class II without reported hospitalization or adverse events is scored at most as Moderate.
Plain-English summary
Siddha Flower Essences, LLC., located in Oxnard, California, is voluntarily recalling Temper Tamer homeopathic oral spray (1 US fl oz., 29.6 mL, NDC 69779-020-01) distributed nationwide in the United States. The recall was initiated on April 28, 2025, due to Current Good Manufacturing Practice (CGMP) deviations.
The affected product is Lot# S22-26424D with an expiration date of September 27, 2027. CGMP deviations indicate that the manufacturing process did not meet FDA standards for facility and equipment maintenance, controls, or procedures.
Consumers who have purchased this product should stop using it. The firm notified customers of this recall through multiple channels including email, fax, letter, press release, telephone, and direct visits. For additional information, consumers should contact Siddha Flower Essences, LLC. or consult the FDA's official recall notice.
The recalled product
- Product
- temper tamer, 1 US fl oz. (29.6 mL), Homeopathic Oral Spray, Manufactured by: Siddha Flower Essences, Oxnard, CA, 93030 NDC 69779-020-01.
- Manufacturer
- Siddha Flower Essences, LLC.
- Category
- Drug — Homeopathic / Oral Spray
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# S22-26424D
- Exp 9/27/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19